R13
Sign inGet started
🇬🇧

NOVALGEN LIMITED

72.11 · Research and experimental development on biotechnologySIC72110SmallID11621264

📍 ARGYLE HOUSE LEVEL 3 NORTHSIDE, JOEL STREET, NORTHWOOD HILLS, MIDDLESEX, HA6 1NW, ENGLAND

Financial data

Sign in to unlock
Revenue
•••••
EBITDA
•••••
Net result
•••••
Total assets
•••••
Equity
•••••
Trade debtors
•••••
Total debtors
•••••
Fiscal year
2025
Revenue, EBIT, net result and balance-sheet figures are as reported to the public register. EBITDA marked Estimated is derived from revenue × the sector-average margin (used where EBITDA is not publicly filed, e.g. France) and is not an audited figure.

Other companies in this sector

Same country and activity, ranked by how much data we hold. The list is free — open any company to see its own page.

CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITEDfinancials→CHARLES RIVER U.K. LIMITEDfinancials→THERADEX (EUROPE) LIMITEDfinancials→CONSTRUCTIVE BIOLOGY LIMITEDfinancials→MEDPHARM LIMITEDfinancials→OXFORD GENE TECHNOLOGY (OPERATIONS) LTDfinancials→

Ownership

2

Who owns this company. Register facts are shown exactly as recorded. We show recorded facts only — never an inferred owner type.

🏢
Corporate ownerShares 25-50%
Ghl Capital Ltd
As recorded in the UK PSC register
🏢
Corporate ownerShares 25-50%
Convergys Capital Limited
As recorded in the UK PSC register

Direction

12
Sign in to unlock
  • •••••••••••
    •••••
  • •••••••••••
    •••••
  • •••••••••••
    •••••
11 board members · 1 corporate officer · unlocks alongside financials

Beneficial owners

2PSC register · UK Companies Actunlocks alongside financials
•••••••••••
•••••
•••••••••••
•••••

Source: Companies House PSC register

Data sourced from official commercial registries. Last updated when this company filed its accounts.

Discover more

More companies in Research and experimental →